Johnson & Johnson (JNJ) Total Liabilities (2009 - 2026)

Johnson & Johnson has disclosed Total Liabilities across 18 years of filings, most recently posting $116.1 billion for Q2 2026.

• In Q2 2026, Total Liabilities rose 1.02% year-over-year to $116.1 billion; the TTM figure through Jun 2026 stood at $116.1 billion (up 1.02% YoY), while the FY2025 annual figure was $117.7 billion, up 8.33% from the prior year.
• Total Liabilities came in at $116.1 billion for Q2 2026 at Johnson & Johnson, down from $119.7 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $125.1 billion in Q2 2023 to a low of $94.8 billion in Q4 2023.
• Average Total Liabilities over 5 years is $109.7 billion, with a median of $109.6 billion recorded in 2024.
• Year-over-year, Total Liabilities rose 20.7% in 2023 and slipped 18.51% in 2024.
• Over 5 years, Total Liabilities stood at $100.5 billion in 2022, then dropped by 1.73% to $98.8 billion in 2023, then grew by 9.95% to $108.6 billion in 2024, then grew by 8.33% to $117.7 billion in 2025, then retreated by 1.34% to $116.1 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $116.1 billion in Q2 2026, $119.7 billion in Q1 2026, and $117.7 billion in Q4 2025.